Technical Analysis for SAGE - Sage Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 139.79 2.44% 3.33
SAGE closed up 2.44 percent on Friday, January 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical SAGE trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 18 Up 5 Days in a Row Strength 0.00%
Jan 17 Wide Bands Range Expansion 2.44%
Jan 17 Up 3 Days in a Row Strength 2.44%
Jan 17 Up 4 Days in a Row Strength 2.44%
Jan 16 Narrow Range Bar Range Contraction 3.09%
Jan 16 Wide Bands Range Expansion 3.09%
Jan 16 Up 3 Days in a Row Strength 3.09%

Older signals for SAGE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat rare central nervous system disorders. The company's lead product candidate includes SAGE-547, an intravenous (IV) agent that is in Phase I/II clinical development as an adjunctive therapy for the treatment of super-refractory status epilepticus (SRSE). Its products in IND-enabling toxicology and safety pharmacology testing comprise SAGE-689, an adjunctive second-line therapy for the treatment of status epilepticus (SE); and SAGE-217, an IV monotherapy for the treatment of refractory status epilepticus, as well as an orally delivered maintenance therapeutic to prevent recurrent seizures in patients whose SE, RSE, or SRSE has resolved. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was founded in 2010 and is based in Cambridge, Massachusetts.
Is SAGE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 195.97
52 Week Low 79.88
Average Volume 615,167
200-Day Moving Average 140.8244
50-Day Moving Average 110.6488
20-Day Moving Average 109.9295
10-Day Moving Average 131.045
Average True Range 9.2008
ADX 32.12
+DI 40.9939
-DI 18.4061
Chandelier Exit (Long, 3 ATRs ) 130.9876
Chandelier Exit (Short, 3 ATRs ) 107.4824
Upper Bollinger Band 153.5903
Lower Bollinger Band 66.2687
Percent B (%b) 0.84
BandWidth 79.434183
MACD Line 8.863
MACD Signal Line 4.9443
MACD Histogram 3.9187
Fundamentals Value
Market Cap 5.23 Billion
Num Shares 37.4 Million
EPS -6.09
Price-to-Earnings (P/E) Ratio -22.95
Price-to-Sales 0.00
Price-to-Book 8.73
PEG Ratio 0.72
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 148.48
Resistance 3 (R3) 147.55 143.72 147.03
Resistance 2 (R2) 143.72 141.51 144.19 146.54
Resistance 1 (R1) 141.76 140.15 142.74 142.69 146.06
Pivot Point 137.93 137.93 138.43 138.40 137.93
Support 1 (S1) 135.97 135.72 136.95 136.90 133.52
Support 2 (S2) 132.14 134.36 132.61 133.04
Support 3 (S3) 130.18 132.14 132.55
Support 4 (S4) 131.11